Bright Minds Biosciences Inc (DRUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,888 | -2,020 | 35 | -2,059 | -1,482 |
| Depreciation Amortization | 43 | 31 | 15 | 54 | 40 |
| Other Working Capital | -460 | -179 | -85 | 29 | -39 |
| Other Operating Activity | 938 | -561 | -1,033 | 616 | 468 |
| Operating Cash Flow | $-5,367 | $-2,730 | $-1,067 | $-1,360 | $-1,014 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 860 | 822 | 2,514 | 0 | N/A |
| Common Stock Repurchased | 1,872 | 1,803 | N/A | N/A | N/A |
| Other Financing Activity | 35,045 | 33,773 | 34,654 | 596 | 610 |
| Financing Cash Flow | $37,776 | $36,398 | $37,168 | $596 | $610 |
| Exchange Rate Effect | 609 | 1,123 | 1,164 | 9 | -4 |
| Beginning Cash Position | 4,136 | 3,984 | 4,085 | 4,959 | 4,931 |
| End Cash Position | 37,153 | 38,776 | 41,350 | 4,204 | 4,523 |
| Net Cash Flow | $33,018 | $34,792 | $37,265 | $-755 | $-408 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,367 | -2,730 | -1,067 | -1,360 | -1,014 |
| Free Cash Flow | -5,367 | -2,730 | -1,067 | -1,360 | -1,014 |